Evidence map›Paper›PMID 32627306›Full record

ArticleBJU international2021

Prostate cancer survivorship essentials framework: guidelines for practitioners.

Jeff Dunn, Anna Green, Nicholas Ralph, Robert U Newton, Andrew Kneebone, Mark Frydenberg, Suzanne K Chambers

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in BJU international, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 5 pooled it
12.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 5 syntheses or guidelines pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Exploring Lived Experiences of Men Diagnosed With Prostate Cancer in Oman: A Qualitative Study.Health expectations : an international journal of public participation in health care and health policy · 2026
    Article
  8. Article
  9. Voices of Black men: reflecting on prostate cancer survivorship care plans.Journal of cancer survivorship : research and practice · 2026
    Article
  10. Article
  11. "We are champions": an investigation on how cancer support group propels patient advocacy, voices, education, mentorship, and support.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  12. Psychosocial factors associated with perceived cognitive functioning in prostate cancer survivors: an exploratory cross-sectional analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Guidelines for genetic testing in prostate cancer: a scoping review.Prostate cancer and prostatic diseases · 2024
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Jeff DunnProstate Cancer Foundation of Australia, Sydney, NSW, Australia.
Anna GreenFaculty of Health, University of Technology Sydney, Ultimo, NSW, Australia.
Nicholas RalphDivision of Research and Innovation, University of Southern Queensland, Springfield, Qld, Australia.ORCID 0000-0002-7404-9996
Robert U NewtonExercise Medicine Research Institute, Edith Cowan University, Perth, WA, Australia.ORCID 0000-0003-0302-6129
Andrew KneeboneRoyal North Shore Hospital, Sydney, NSW, Australia.
Mark FrydenbergMonash University, Melbourne, Vic., Australia.
Suzanne K ChambersDivision of Research and Innovation, University of Southern Queensland, Springfield, Qld, Australia.ORCID 0000-0003-2369-6111
University of Technology Sydney · AUEdith Cowan University · AUMonash University · AUThe University of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo develop contemporary and inclusive prostate cancer survivorship guidelines for the Australian setting. PARTICIPANTS AND

methodsA four-round iterative policy Delphi was used, with a 47-member expert panel that included leaders from key Australian and New Zealand clinical and community groups and consumers from diverse backgrounds, including LGBTQIA people and those from regional, rural and urban settings. The first three rounds were undertaken using an online survey (94-96% response) followed by a fourth final face-to-face panel meeting. Descriptors for men's current prostate cancer survivorship experience were generated, along with survivorship elements that were assessed for importance and feasibility. From these, survivorship domains were generated for consideration.

resultsSix key descriptors for men's current prostate cancer survivorship experience that emerged were: dealing with side effects; challenging; medically focused; uncoordinated; unmet needs; and anxious. In all, 26 survivorship elements were identified within six domains: health promotion and advocacy; shared management; vigilance; personal agency; care coordination; and evidence-based survivorship interventions. Consensus was high for all domains as being essential. All elements were rated high on importance but consensus was mixed for feasibility. Seven priorities were derived for immediate action.

conclusionThe policy Delphi allowed a uniquely inclusive expert clinical and community group to develop prostate cancer survivorship domains that extend beyond traditional healthcare parameters. These domains provide guidance for policymakers, clinicians, community and consumers on what is essential for step change in prostate cancer survivorship outcomes.

Indexed as

Cancer SurvivorsSurvivorshipAdolescentAdultAgedAged, 80 and overAustraliaConsensusDecision Making, SharedDelphi TechniqueHealth PromotionHumansMaleMiddle AgedPatient NavigationPatient Participationimplementation#PCSMprostate cancer#ProstateCancerquality of lifesurvivorship

Identifiers

PMID32627306
PMCPMC9291032
OpenAlexW3039948917

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.